isnt aducanumab also the one that doesnt work and majority of doctors refuse to prescribe? brain bleeding in 21% of the patients? imagine if leronlimab caused bleeding on the brain? the entire executive suite would be arrested, and maybe a few of us stockholders just for fun.

obviously a misprint linking cytodyn to neurimmune, should be -

neurimmune : biogen

Quote:

---

Neurimmune is a biopharmaceutical company translating human immune memory into antibody therapeutics. Neurimmune scientists discovered aducanumab together with a team of researchers at the University of Zurich. Neurimmune licensed aducanumab to Biogen and collaborates with Biogen on its development. In 2021, the U.S. FDA approved aducanumab for the treatment of Alzheimer’s disease.

These are the folks that brought is aducanumab. The one no one at FDA voted to approve, but it got approved in spite of the vote.

Read More: https://investorshangout.com/post/newpost/605...z7n0sFj0of

---